BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peters M, Vierling J, Gershwin ME, Milich D, Chisari FV, Hoofnagle JH. Immunology and the liver. Hepatology 1991;13:977-94. [PMID: 2030002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 84] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Man Shrestha S. Liver Cirrhosis in Chronic Hepatitis B: is it due to Hepatic Vena Cava Syndrome: case report. JHVRV 2022;9:65-73. [DOI: 10.15406/jhvrv.2022.09.00251] [Reference Citation Analysis]
2 Basina VV, Arsentieva NA, Batsunov OK, Lyubimova NE, Semenov AV, Esaulenko EV, Totolian AA. EXPRESSION PATTERNS OF CHEMOKINE RECEPTORS CXCR3 AND CCR6, AND THEIR LIGANDS IN PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC HEPATITIS C DURING ANTIVIRAL THERAPY USING PEGYLATED INTERFERONS. Med immunol 2019;21:107-120. [DOI: 10.15789/1563-0625-2019-1-107-120] [Reference Citation Analysis]
3 Dembek C, Protzer U. Mouse models for therapeutic vaccination against hepatitis B virus. Med Microbiol Immunol 2015;204:95-102. [DOI: 10.1007/s00430-014-0378-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
4 Yang FQ, Yu YY, Wang GQ, Chen J, Li JH, Li YQ, Rao GR, Mo GY, Luo XR, Chen GM. A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy. J Viral Hepat 2012;19:581-93. [PMID: 22762143 DOI: 10.1111/j.1365-2893.2012.01589.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
5 Soliman HH, Nagy H, Kotb N, Alm El-Din MA. The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma. Int J Biol Markers. 2012;27:e125-e131. [PMID: 22388957 DOI: 10.5301/jbm.2012.9097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
6 Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y, Qu Z, Cui J, Zhang G, Liang X, Ma C, Gao C, Chen Y, Liu S. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Molecular Immunology 2011;48:1203-8. [DOI: 10.1016/j.molimm.2011.03.002] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 5.7] [Reference Citation Analysis]
7 Lobaina Y, Trujillo H, García D, Gambe A, Chacon Y, Blanco A, Aguilar JC. The effect of the parenteral route of administration on the immune response to simultaneous nasal and parenteral immunizations using a new HBV therapeutic vaccine candidate. Viral Immunol 2010;23:521-9. [PMID: 20883166 DOI: 10.1089/vim.2010.0024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
8 Wu F, Cao J, Jiang J, Yu B, Xu Q. Ruscogenin glycoside (Lm-3) isolated from Liriope muscari improves liver injury by dysfunctioning liver-infiltrating lymphocytes. Journal of Pharmacy and Pharmacology 2001;53:681-8. [DOI: 10.1211/0022357011775802] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
9 Dancygier H. The Liver as an Immune Organ. Clinical Hepatology 2010. [DOI: 10.1007/978-3-540-93842-2_11] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
10 Kimura K, Nagaki M, Matsuura T, Moriwaki H, Kakimi K. Pathological role of CD44 on NKT cells in carbon tetrachloride-mediated liver injury. Hepatol Res 2009;39:93-105. [PMID: 18721153 DOI: 10.1111/j.1872-034X.2008.00409.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
11 Gong F, Shen Y, Zhang C, Xu J, Wu X, Hua Z, Xu Q. Dregea volubilis Ameliorates Concanavalin A-Induced Liver Injury by Facilitating Apoptosis of Activated T Cells. Exp Biol Med (Maywood) 2008;233:1124-32. [DOI: 10.3181/0801-rm-15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
12 Kang ES, Kim CY, Kim SB, Im SJ, Yang SH, Sung YC, Kim BM. In vivo kinetics and biodistribution of HB-110, a novel HBV DNA vaccine, after administration in Mice. Arch Pharm Res 2007;30:355-60. [DOI: 10.1007/bf02977618] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
13 Pol S, Michel ML. Therapeutic vaccination in chronic hepatitis B virus carriers. Expert Rev Vaccines 2006;5:707-16. [PMID: 17181443 DOI: 10.1586/14760584.5.5.707] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
14 Bagis H, Arat S, Mercan HO, Aktoprakligil D, Caner M, Turanli ET, Baysal K, Turgut G, Sekmen S, Cirakoglu B. Stable transmission and expression of the hepatitis B virus total genome in hybrid transgenic mice until F10 generation. J Exp Zool A Comp Exp Biol 2006;305:420-7. [PMID: 16489557 DOI: 10.1002/jez.a.277] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
15 Michel ML, Mancini-Bourgine M. Therapeutic vaccination against chronic hepatitis B virus infection. J Clin Virol. 2005;34 Suppl 1:S108-S114. [PMID: 16461209 DOI: 10.1016/S1386-6532(05)80019-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
16 Tanaka H, Ueda H, Hamagami H, Yukawa S, Ichinose M, Miyano M, Mimura K, Nishide I, Zhang BX, Wang SW, Zhou SO, Li BH. Mutations in hepatitis B virus core regions correlate with hepatocellular injury in Chinese patients with chronic hepatitis B. World J Gastroenterol 2005; 11(30): 4693-4696 [PMID: 16094712 DOI: 10.3748/wjg.v11.i30.4693] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
17 Mancini-bourgine M, Michel M. Traitement des infections chroniques dues au virus de l’hépatite B par vaccination thérapeutique. Therapies 2005;60:257-65. [DOI: 10.2515/therapie:2005033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
18 Borrow P, Hou S, Gloster S, Ashton M, Hyland L. Virus infection-associated bone marrow B cell depletion and impairment of humoral immunity to heterologous infection mediated by TNF-alpha/LTalpha. Eur J Immunol 2005;35:524-32. [PMID: 15657949 DOI: 10.1002/eji.200425597] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
19 Sprengers D, van der Molen RG, Kusters JG, Janssen HL. Coarse vs. fine needle aspiration biopsy. J Hepatol 2004;41:503-4; author reply 504. [PMID: 15336460 DOI: 10.1016/j.jhep.2004.04.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
20 Lee JY, Chae DW, Kim SM, Nam ES, Jang MK, Lee JH, Kim HY, Yoo JY. Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection. J Viral Hepat 2004;11:130-5. [PMID: 14996347 DOI: 10.1046/j.1365-2893.2003.00486.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
21 Lebray P, Vallet-Pichard A, Michel ML, Fontaine H, Sobesky R, Bréchot C, Pol S. Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection. J Hepatol 2003;39 Suppl 1:S151-9. [PMID: 14708695 DOI: 10.1016/s0168-8278(03)00336-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
22 Szkaradkiewicz A, Jopek A, Wysocki J, Grzymislawski M, Malecka I, Woźniak A. HBcAg-specific cytokine production by CD4 T lymphocytes of children with acute and chronic hepatitis B. Virus Res 2003;97:127-33. [PMID: 14602204 DOI: 10.1016/j.virusres.2003.08.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
23 Mutchnick MG, Siddiqui FA. Acute and Chronic Hepatitis B. Atlas of the Liver 2004. [DOI: 10.1007/978-1-4615-6502-4_4] [Reference Citation Analysis]
24 Michalak TI. Immunology of hepatitis B virus. Hepatitis Prevention and Treatment 2004. [DOI: 10.1007/978-3-0348-7903-3_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
25 Durowicz S, Olszewski WL. A liver perfusion model for studies of selective adherence and transient halting of portal blood leukocytes in sinusoids. J Immunol Methods 2003;272:117-24. [PMID: 12505717 DOI: 10.1016/s0022-1759(02)00438-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Dancygier H, Leuschner U, Häussinger D. Physiologie. Klinische Hepatologie 2003. [DOI: 10.1007/978-3-642-55902-0_4] [Reference Citation Analysis]
27 Ohba K, Omagari K, Murase K, Hazama H, Masuda J, Kinoshita H, Isomoto H, Mizuta Y, Miyazaki M, Murata I, Kohno S. A possible mouse model for spontaneous cholangitis: serological and histological characteristics of MRL/lpr mice. Pathology 2002;34:250-6. [PMID: 12109786 DOI: 10.1080/00313020220131318] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
28 Kunitani H, Shimizu Y, Murata H, Higuchi K, Watanabe A. Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. J Hepatol 2002;36:734-41. [PMID: 12044522 DOI: 10.1016/s0168-8278(02)00062-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 3.0] [Reference Citation Analysis]
29 Yamauchi K, Akbar SM, Horiike N, Michitaka K, Onji M. Increased serum levels of macrophage inflammatory protein-3alpha in chronic viral hepatitis: prognostic importance of macrophage inflammatory protein-3alpha during interferon therapy in chronic hepatitis C. J Viral Hepat 2002;9:213-20. [PMID: 12010510 DOI: 10.1046/j.1365-2893.2002.00354.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
30 Martin NC, McCullough CT, Bush PG, Sharp L, Hall AC, Harrison DJ. Functional analysis of mouse hepatocytes differing in DNA content: volume, receptor expression, and effect of IFNgamma. J Cell Physiol 2002;191:138-44. [PMID: 12064456 DOI: 10.1002/jcp.10057] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
31 Neumann UP, Langrehr JM, Naumann U, Lang M, Rayes N, Steinmüller T, Radtke C, Neuhaus P. Impact of HLA-compatibilities in patients undergoing liver transplantation for HBV-cirrhosis. Clin Transplant 2002;16:122-9. [PMID: 11966782 DOI: 10.1034/j.1399-0012.2002.1o008.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
32 Michel ML, Pol S, Brechot C, Tiollais P. Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future. Vaccine 2001;19:2395-9. [PMID: 11257367 DOI: 10.1016/s0264-410x(00)00461-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 2.2] [Reference Citation Analysis]
33 Rose M, Scholler G, Jörres A, Danzer G, Klapp BF. Patients' expressions of complaints as a predictor of the course of acute hepatitis A. J Psychosom Res 2000;48:107-13. [PMID: 10719126 DOI: 10.1016/s0022-3999(99)00071-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
34 Weiner AJ, Chien D, Choo Q, Coates SR, Kuo G, Houghton M. 7 Humoral response to hepatitis C virus. Hepatitis C. Elsevier; 2000. pp. 125-45. [DOI: 10.1016/s1874-5326(00)80011-3] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
35 Moreno Otero R. Hepatitis autoinmune. Medicine - Programa de Formación Médica Continuada Acreditado 2000;8:693-701. [DOI: 10.1016/s0304-5412(00)70131-4] [Reference Citation Analysis]
36 Akbar SM, Yamamoto K, Abe M, Ninomiya T, Tanimoto K, Masumoto T, Michitaka K, Horiike N, Onji M. Potent synergistic effect of sho-saiko-to, a herbal medicine, during vaccine therapy in a murine model of hepatitis B virus carrier. Eur J Clin Invest 1999;29:786-92. [PMID: 10469167 DOI: 10.1046/j.1365-2362.1999.00533.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
37 Xu Q, Wu F, Cao J, Chen T, Jiang J, Saiki I, Koda A. Astilbin selectively induces dysfunction of liver-infiltrating cells--novel protection from liver damage. Eur J Pharmacol 1999;377:93-100. [PMID: 10448932 DOI: 10.1016/s0014-2999(99)00401-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 1.5] [Reference Citation Analysis]
38 Akbar SM, Abe M, Masumoto T, Horiike N, Onji M. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells. J Hepatol 1999;30:755-64. [PMID: 10365798 DOI: 10.1016/s0168-8278(99)80125-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 1.7] [Reference Citation Analysis]
39 Kano A, Haruyama T, Akaike T, Watanabe Y. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochem Biophys Res Commun 1999;257:672-7. [PMID: 10208842 DOI: 10.1006/bbrc.1999.0276] [Cited by in Crossref: 118] [Cited by in F6Publishing: 119] [Article Influence: 4.9] [Reference Citation Analysis]
40 Fragulidis GP, Cirocco RE, Weppler D, Berho M, Gillian G, Markou M, Viciana A, Esquenazi V, Nery JR, Miller J, Reddy KR, Tzakis AG. In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease. Transplantation 1998;66:1472-6. [PMID: 9869088 DOI: 10.1097/00007890-199812150-00010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
41 Hiasa Y, Horiike N, Akbar SM, Saito I, Miyamura T, Matsuura Y, Onji M. Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes. Biochem Biophys Res Commun 1998;249:90-5. [PMID: 9705837 DOI: 10.1006/bbrc.1998.9089] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 1.7] [Reference Citation Analysis]
42 Xu Q, Jiang J, Cao J, Wu F, Fujii H, Saiki I. LEA-1/ICAM-1 interaction is essentially involved in the pathogenesis of delayed-type hypersensitivity-induced liver injury to picryl chloride. Life Sci 1998;62:1281-92. [PMID: 9566770 DOI: 10.1016/s0024-3205(98)00062-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
43 Pessoa MG, Wright TL. Hepatitis C infection in transplantation. Clin Liver Dis 1997;1:663-90. [PMID: 15560065 DOI: 10.1016/s1089-3261(05)70328-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
44 Uchida T, Saitoh T, Shinzawa H. Mutations of the X region of hepatitis B virus and their clinical implications. Pathol Int 1997;47:183-93. [PMID: 9103208 DOI: 10.1111/j.1440-1827.1997.tb04479.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
45 Xu Q, Lu J, Wang R, Wu F, Cao J, Chen X. Liver injury model induced in mice by a cellular immunologic mechanism--study for use in immunopharmacological evaluations. Pharmacol Res 1997;35:273-8. [PMID: 9264042 DOI: 10.1006/phrs.1997.0164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
46 Feng ZJ, Niu RM, Ren XL, Yao XX. Cellular immune function and liver damage in post-hepatitic cirrhosis. World J Gastroenterol 1997; 3(1): 22-23 [PMID: 27006578 DOI: 10.3748/wjg.v3.i1.22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Zinkernagel RM. Immunology and immunity studied with viruses. Ciba Found Symp 1997;204:105-25; discussion 125-9. [PMID: 9107415 DOI: 10.1002/9780470515280.ch8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
48 Akbar SM, Kajino K, Tanimoto K, Kurose K, Masumoto T, Michitaka K, Horiike N, Onji M. Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J Hepatol 1997;26:131-7. [PMID: 9148003 DOI: 10.1016/s0168-8278(97)80019-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.3] [Reference Citation Analysis]
49 Fukuda R, Ishimura N, Ishihara S, Chowdhury A, Morlyama N, Nogami C, Miyake T, Niigaki M, Tokuda A, Satoh S, Sakai S, Akagi S, Watanabe M, Fukumoto S. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver 1996;16:390-9. [PMID: 9021719 DOI: 10.1111/j.1600-0676.1996.tb00768.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 2.3] [Reference Citation Analysis]
50 Terrault NA, Wright TL. Therapy for chronic hepatitis B infection. Adv Exp Med Biol 1996;394:189-205. [PMID: 8815686 DOI: 10.1007/978-1-4757-9209-6_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
51 Terrault NA, Wright TL, Pereira BJ. HEPATITIS C INFECTION IN THE TRANSPLANT RECIPIENT. Infectious Disease Clinics of North America 1995;9:943-64. [DOI: 10.1016/s0891-5520(20)30710-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
52 Löhr HF, Weber W, Schlaak J, Goergen B, Meyer zum Buschenfelde KH, Gerken G. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology 1995;22:61-8. [PMID: 7601434 DOI: 10.1002/hep.1840220110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 25] [Article Influence: 0.0] [Reference Citation Analysis]
53 Gotoh K, Mima S, Uchida T, Shikata T, Yoshizawa K, Irie M, Mizui M. Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti-hepatitis B core antibody. J Med Virol 1995;46:201-6. [PMID: 7561790 DOI: 10.1002/jmv.1890460306] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 0.9] [Reference Citation Analysis]
54 Anwer MS, Meyer DJ. Bile acids in the diagnosis, pathology, and therapy of hepatobiliary diseases. Vet Clin North Am Small Anim Pract 1995;25:503-17. [PMID: 7785176 DOI: 10.1016/s0195-5616(95)50039-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
55 Paterlini P, Bréchot C. Primary Liver Cancer and Hepatitis B and C Viruses. Molekularbiologische Grundlagen der Gastroenterologie 1995. [DOI: 10.1007/978-3-642-79782-8_8] [Reference Citation Analysis]
56 Wright TL, Pereira B. Liver transplantation for chronic viral hepatitis. Liver Transpl Surg 1995;1:30-42. [PMID: 9346539 DOI: 10.1002/lt.500010108] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
57 Zinkernagel RM. Immunosuppression by a noncytolytic virus via T cell mediated immunopathology. Implication for AIDS. Adv Exp Med Biol 1995;374:165-71. [PMID: 7572389 DOI: 10.1007/978-1-4615-1995-9_14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
58 Napoli J, Bishop GA, McCaughan GW. Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. Gastroenterology 1994;107:789-98. [PMID: 8076766 DOI: 10.1016/0016-5085(94)90128-7] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 2.2] [Reference Citation Analysis]
59 Treichel U, McFarlane BM, Seki T, Krawitt EL, Alessi N, Stickel F, McFarlane IG, Kiyosawa K, Furuta S, Freni MA. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology 1994;107:799-804. [PMID: 8076767 DOI: 10.1016/0016-5085(94)90129-5] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 2.2] [Reference Citation Analysis]
60 Allen PM, Zinkernagel RM. Promethean viruses? Nature 1994;369:355-6. [PMID: 7515164 DOI: 10.1038/369355a0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
61 Zinkernagel RM, Hengartner H. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today 1994;15:262-8. [PMID: 7915115 DOI: 10.1016/0167-5699(94)90005-1] [Cited by in Crossref: 196] [Cited by in F6Publishing: 201] [Article Influence: 6.8] [Reference Citation Analysis]
62 Manns MP, Krüger M. Immunogenetics of chronic liver diseases. Gastroenterology 1994;106:1676-97. [PMID: 8194717 DOI: 10.1016/0016-5085(94)90427-8] [Cited by in Crossref: 93] [Cited by in F6Publishing: 93] [Article Influence: 3.2] [Reference Citation Analysis]
63 Chazouillères O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343:142-6. [PMID: 7904004 DOI: 10.1016/s0140-6736(94)90934-2] [Cited by in Crossref: 232] [Cited by in F6Publishing: 227] [Article Influence: 8.0] [Reference Citation Analysis]
64 Boberg KM, Lundin KE, Schrumpf E. Etiology and pathogenesis in primary sclerosing cholangitis. Scand J Gastroenterol Suppl 1994;204:47-58. [PMID: 7824878 DOI: 10.3109/00365529409103625] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.1] [Reference Citation Analysis]
65 Franceschini N, Goncalves LF, Prompt CA, Barros SG, Cerski CT, Costa CA. Fine needle aspirative biopsy of the liver in HBsAG-positive patients with end-stage renal failure. Ren Fail 1994;16:491-9. [PMID: 7938757 DOI: 10.3109/08860229409045080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
66 Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993;67:7522-32. [PMID: 7693974 DOI: 10.1128/JVI.67.12.7522-7532.1993] [Cited by in Crossref: 206] [Cited by in F6Publishing: 217] [Article Influence: 6.9] [Reference Citation Analysis]
67 Wright T. The threat of hepatitis B virus recurrence: a sword of Damocles to the liver transplant recipient. Hepatology 1993;18:219-22. [PMID: 8325614 DOI: 10.1002/hep.1840180133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
68 Kyburz D, Speiser DE, Battegay M, Hengartner H, Zinkernagel RM. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins. Eur J Immunol 1993;23:1540-5. [PMID: 8325330 DOI: 10.1002/eji.1830230722] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
69 Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362:758-61. [PMID: 8469287 DOI: 10.1038/362758a0] [Cited by in Crossref: 912] [Cited by in F6Publishing: 966] [Article Influence: 30.4] [Reference Citation Analysis]
70 Perrillo RP. Interferon in the management of chronic hepatitis B. Dig Dis Sci 1993;38:577-93. [PMID: 8462360 DOI: 10.1007/BF01316785] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 2.1] [Reference Citation Analysis]
71 Wright TL. Cytomegalovirus infection and vanishing bile duct syndrome: culprit or innocent bystander? Hepatology 1992;16:494-6. [PMID: 1322352 DOI: 10.1002/hep.1840160231] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 0.8] [Reference Citation Analysis]
72 Dusheiko G, Xu J, Zuckermann AJ. Clinical Diagnosis of Hepatitis B Infection: Applications of the Polymerase Chain Reaction. In: Becker Y, Darai G, editors. Diagnosis of Human Viruses by Polymerase Chain Reaction Technology. Berlin: Springer Berlin Heidelberg; 1992. pp. 67-85. [DOI: 10.1007/978-3-642-84766-0_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]